Provectus Biopharmaceuticals Announces Presentation of 2-Year Landmark Data from Combination Therapy Trial of PV-10® and KEYTRUDA® for Checkpoint-Naïve Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020
September 17, 2020 06:00 ET
|
Provectus Biopharmaceuticals Inc.
62% 2-year OS; median OS not reachedStable, non-overlapping safety profileClinical synergy between PV-10 and immune checkpoint blockadeData compare favorably to approved therapies for patient...
PETVIVO HOLDINGS, INC. HIRES DR. DAVID B MASTERS AS DIRECTOR OF SCIENCE AND TECHNOLOGY
September 10, 2020 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Sept. 10, 2020 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for...
Rafael Pharmaceuticals Enters into Collaboration with the National Institutes of Health (NIH) to Test CPI-613® (devimistat) in Cytokine Independent (Acute) HTLV-1 Associated Adult T-cell Leukemia/Lymphoma
October 17, 2019 09:00 ET
|
Rafael Pharmaceutical Inc.
Cranbury, NJ, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that...
Historic NIH research grants to UGA, Emory could exceed $200 million
October 02, 2019 11:26 ET
|
Georgia Research Alliance
Atlanta, GA, Oct. 02, 2019 (GLOBE NEWSWIRE) -- This week’s news that the National Institutes of Health (NIH) has awarded two Georgia universities major grants to advance work toward a universal flu...
Steadman Philippon Research Institute Receives Third NIH Grant
August 22, 2019 13:46 ET
|
The Steadman Clinic and Steadman Philippon Research Institute
Vail, Colorado, Aug. 22, 2019 (GLOBE NEWSWIRE) -- The National Institutes of Health (NIH) awarded Steadman Philippon Research Institute (SPRI) a grant to study muscle-derived stem cells (MDSCs)...
Steadman Philippon Research Institute Receives NIH Award for Research
August 20, 2019 13:35 ET
|
The Steadman Clinic and Steadman Philippon Research Institute
Vail, Colorado, Aug. 20, 2019 (GLOBE NEWSWIRE) -- The National Institutes of Health (NIH) has awarded Steadman Philippon Research Institute (SPRI) a grant to study the correlation between...
Steadman Philippon Research Institute Awarded First NIH Award
August 19, 2019 14:43 ET
|
The Steadman Clinic and Steadman Philippon Research Institute
Vail, Colorado, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) has received a research award from the National Institutes of Health (NIH) to investigate bone...
Novan Advances Women’s Health Business Unit with Non-Dilutive Funding
August 14, 2019 08:15 ET
|
Novan, Inc.
Company has received NIH federal grant of approximately $223,000Anticipates additional federal grant of approximately $1.0 millionWomen’s health initiative to focus on potential HPV related onco-virus...
National Institutes of Health Awards Morgan State University a Total of $35 Million in New Grant Funding for Research
August 09, 2019 11:04 ET
|
Morgan State University
Baltimore, Maryland, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Morgan State University has secured a total of $35 million in new grant awards from the National Institutes of Health (NIH), the world’s...
Corbus Pharmaceuticals to Host 2019 R&D Day in New York City
June 17, 2019 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
- R&D Day to be live video webcasted on Friday, June 21st at 10:00 AM ET - Norwood, MA, June 17, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the...